Targeting MHC-I inhibitory pathways for cancer immunotherapy is a research paper published in Trends in Immunology (2024). On theSindex it has a DataRank of 0.637. It has been cited 69 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.637
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →American Society of Hematology
Grant: CRI4179
National Heart, Lung, and Blood Institute
Grant: 1R01CA228135
National Heart, Lung, and Blood Institute
Grant: 1R01HL159175
National Heart, Lung, and Blood Institute
Grant: R01CA173636
National Heart, Lung, and Blood Institute
Grant: R01CA216421
National Heart, Lung, and Blood Institute
Grant: R01CA242020
NIAID NIH HHS
Grant: R21 AI163924
NHLBI NIH HHS
Grant: R01 HL159175
NCI NIH HHS
Grant: R01 CA169784
NCI NIH HHS
Grant: R01 CA269898
NCI NIH HHS
Grant: R01 CA271455
NCI NIH HHS
Grant: R01 CA228135
NCI NIH HHS
Grant: R37 CA273333
NCI NIH HHS
Grant: R01 CA283574
FWCI
10.75
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals